Analysis of QT Interval Prolongation of Amiselimod in Healthy Subjects: A Phase 1 Randomized Controlled Trial

被引：0
|
作者：
Vivian, Lee [1 ]
Omeed, Alipour [2 ]
Tapas, Tejura [1 ]
Melissa, Wilson [1 ]
Zoe, Memel [3 ]
Kyle, Cologne [1 ]
Caroline, Hwang [4 ]
Ling, Shao [1 ]
机构：
[1] Univ Southern Calif, Keck Sch Med, Los Angeles, CA 90007 USA
[2] Univ Washington, Sch Med, Seattle, WA USA
[3] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA
[4] Hoag Hosp, Newport Beach, CA USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2020年 / 115卷
关键词：
D O I：
10.14309/01.ajg.0000722852.81814.04
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P014
引用
收藏
页码：S4 / S5
页数：2
相关论文
共 50 条
  • [1] Prolongation of QT interval by terbutaline in healthy subjects
    Kuusela, TA
    Jartti, TT
    Tahvanainen, KUO
    Kaila, TJ
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2005, 45 (02) : 175 - 181
  • [2] The assessment of drug induced QT interval prolongation in healthy subjects:: QTc interval, QT (QTc) dispersion?
    Nemat, S
    Prasad, V
    Oliver, S
    Hedge, A
    Amakye, D
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (02) : 90 - 90
  • [3] Randomized, Controlled, Thorough QT/QTc Study Shows Absence of QT Prolongation with Luseogliflozin in Healthy Japanese Subjects
    Kumagai, Yuji
    Hasunuma, Tomoko
    Sakai, Soichi
    Ochiai, Hidekazu
    Samukawa, Yoshishige
    PLOS ONE, 2015, 10 (10):
  • [4] SAFETY OF AMISELIMOD IN HEALTHY SUBJECTS: RESULTS FROM A PHASE 1 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    Hanauer, Stephen
    O'Reilly, Terry
    Lester, Robert
    Slatkin, Neal
    Lee, Jimin
    Franklin, Howard
    Bulawski, Angela
    Israel, Robert
    GASTROENTEROLOGY, 2021, 160 (03) : S1 - S2
  • [5] SAFETY OF AMISELIMOD IN HEALTHY SUBJECTS: RESULTS FROM A PHASE 1 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    Hanauer, Stephen
    O'Reilly, Terry
    Lester, Robert
    Slatkin, Neal
    Lee, Jimin
    Franklin, Howard
    Bulawski, Angela
    Israel, Robert
    INFLAMMATORY BOWEL DISEASES, 2021, 27 : S1 - S1
  • [6] Concentration QT interval modeling of intranasally administered zavegepant in healthy subjects shows absence of QT prolongation
    Bertz, R.
    Stringfellow, J.
    Bhardwaj, R.
    Donohue, M. K.
    Madonia, J.
    Anderson, M.
    Stock, D. A.
    Anderson, M.
    Coric, V
    Croop, R.
    HEADACHE, 2022, 62 : 105 - 106
  • [7] Pharmacokinetic-pharmacodynamic analysis to evaluate the effect of moxifloxacin on QT interval prolongation in healthy Korean male subjects
    Hong, Taegon
    Han, Seunghoon
    Lee, Jongtae
    Jeon, Sangil
    Park, Gab-Jin
    Park, Wan-Su
    Lim, Kyoung Soo
    Chung, Jae-Yong
    Yu, Kyung-Sang
    Yim, Dong-Seok
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 1233 - 1245
  • [8] QT interval prolongation in diabetic subjects: Effects on mortality
    Diem, P
    Zanchin, L
    Suter, SL
    Teuscher, A
    DIABETOLOGIA, 1999, 42 : A296 - A296
  • [9] Impact of age on QT interval and QT dispersion in healthy subjects: a regression analysis
    Mangoni, AA
    Kinirons, MT
    Swift, CG
    Jackson, SHD
    AGE AND AGEING, 2003, 32 (03) : 326 - 331
  • [10] QT-interval prolongation in diabetic subjects: Effects on mortality
    Diem, P
    Suter, SL
    Zanchin, L
    Teuscher, A
    DIABETOLOGIA, 1998, 41 : A307 - A307
12345